Stromal cell CD9 and the differentiation of hematopoietic stem/progenitor cells

Leukemia and Lymphoma

Volumn 38, Issue 1-2, 2000, Pages 147-152

  Oritani, Kenji ^a   Aoyama, Keisuke ^a   Tomiyama, Yoshiaki ^a   Kincade, Paul W ^b   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

CD9; Hematopoiesis; Stem cell; Stromal cell

Indexed keywords

CD9 ANTIGEN; INTEGRIN; PROTEIN;

ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; STROMA CELL;

ANIMALS; ANTIGENS, CD; CELL COMMUNICATION; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; STROMAL CELLS;

EID: 0034050417     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kincade, P.W., Oritani, K., Zheng, Z., Borghesi, L., Smithson, G. and Yamashita, Y. (1998) Cell interaction molecules utilized in bone marrow. Cell Adhes Commun, 6, 211-215.
2. Oritani, K. and Kincade, P.W. (1998) Lymphopoiesis and matrix glycoprotein SC1/ECM2. Leuk Lymphoma, 32, 1-7.
3. von Kalle, C., Glimm, H., Schulz, G., Mertelsmann, R. and Henschler, R. (1998) New developments in hematopoietic stem cell expansion. Curr Opin Hematol, 5, 79-86.
4. Brugger, W. and Kanz, L. (1996) Ex vivo expansion of hematopoietic precursor cells. Curr Opin Hematol, 3, 235-240.
5. Spyridonidis, A., Mertelsmann, R. and Henschler, R. (1996) Hematopoietic cell proliferation and differentiation. Curr Opin Hemalol, 3, 321-328.
6. Wright, M.D. and Tomlinson, M.G. (1994) The ins and outs of the transmembrane 4 superfamily. Immunol Today, 15, 588-593.
7. Maecker, H.T., Todd, S.C. and Levy, S. (1997) The tetraspan superfamily: molecular facilitators. FASEB J, 11, 428-442.
8. Oritani, K., Wu, X., Medina, K., Hudson, J., Miyake, K., Gimble, J.M., Burstein, S.A. and Kincade, P.W. (1996) Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood, 87, 2252-2261.
9. Aoyama, K., Oritani, K., Yokota, T., Ishikawa, J., Nishiura, T, Miyake, K., Kanakura, Y., Tomiyama, Y. Kincade, P.W. and Matsuzawa, Y. (1999) Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells. Blood, 93, 2586-2594.
10. Radford, K.J., Thorne, R.F. and Mersey, P. (1996) CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with betal integrins in human melanoma. Biochem Biophys Res Commun, 222, 13-28.
11. Berditchevski, F., Bazzoni, G. and Hemler, M.E. (1995) Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem, 270, 17784-17790.
12. Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C., Billard, M., Conjeaud, H. and Boucheix, C. (1996) CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol, 26, 2657-2665.
13. Imai, T. and Yoshie, O. (1993) C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type I are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol, 151, 6470-6481.
14. Tedder, T.F., Zhou, L.J. and Engel, P. (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today, 15, 437-442.
15. Boucheix, C., Benoit, P., Frachet, P., Billard, M., Worthington, R.E., Gagnon, J. and Uzan, G. (1991) Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem, 266, 17-122.
16. Atkinson, B., Ernst, C.S., Christ, B.F., Herlyn, M., Blaszczyk, M., Ross, A.M., Herlyn, D., Steplewski, Z. and Koprowski, H. (1984) Identification of melanoma-associated antigens usinf fixed tissue screening of antibodies. Cancer Res, 44, 2577-2581.
17. Ikeyama, S., Koyama, M., Yamaoka, M., Sasada, R. and Miyake, M. (1993) Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med, 177, 1231-1237.
18. Miyake, M., Nakano, K., Itoi, S.I., Koh, T. and Taki, T. (1996) Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res, 56, 1244-1249.
19. Oren, R., Takahashi, S., Doss, C., Levy, R. and Levy, S. (1990) TAPA-I, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol, 10, 4007-4015.
20. Todd, S.C., Lipps, S.O., Crisa, L., Salomon, D.R. and Tsoukas, C.D. (1996) CD81 expressed on human thymocytes mediates integrin activation and IL-2-dependent proliferation. J Exp Med, 184, 2055-2060.
21. Slupsky, J.R., Seehafer, J.G., Tang, S-C., Masselis-Smith, A. and Shaw, A.R.E. (1989) Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoproiein Iib-IIIa complex. J Biol Chem, 264, 12289-12293.
22. Higashihara, M., Maeda, H., Shibata, Y., Kume, S. and Ohashi, T. (1985) A monoclonal antihuman platelet antibody: a new platelet aggregating substance. Blood, 65, 382-391.
23. Miller, J.L., Kupinski, J.M. and Hustad, K.O. (1986) Characterization of a platelet membrane protein of low molecular weight associated with platelet activation following binding by monoclonal antibody AG-1. Blood, 68, 743-751.
24. Anton, E.S., Hadjiargyrou, M., Patterson, P.H., Matthew, W.D. (1995) CD9 plays a role in Schwann cell migration in vitro. J Neurosci, 15, 584-595.
25. Forsyth, K.D. (1991) Anti-CD9 antibodies augment neutrophil adherence to endothelium. Immunology, 12, 292-296.
26. Deng, C.T., Terasaki, P.I., Iwaki, Y., Hofman, F.M., Koeffler, P., Cahan, L., Awar, N. and Billing, R. (1983) A monoclonal antibody crossreactive with human platelets, megakaryocytes, and common acute lymphocytic leukemic cells. Blood, 61, 759-764.
27. Kemshead, J.T., Fritschy, J., Asser, U., Sutherland, R. and Greaves, M.F. (1982) Monoclonal antibodies defining markers with apparent selectivity for particular haemopoietic cell types may also detect antigens on cells of neural crest origin. Hybridoma, 1, 109-123.
28. Allen, T.D. and Testa, N.G. (1991) Cellular interactions in erythroblastic islands in long-term hone marrow cultures, as studied by time-lapse video. Blood Cells, 17, 29-38.
29. Tsai, S., Bartelmez, S., Stinicka, E. and Collins, S. (1994) Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev, 8, 2831-2841.
30. Masellis-Smith, A., Jensen, G.S., Seehafer, J.G., Slupsky, J.R. and Shaw, A, R.E. (1990) Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J Immunol, 144, 1607-1613.
31. Masellis-Smith, A. and Shaw, A.R. (1994) CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J Immunol, 152, 2768-2777.
32. Brown, J.G., Almond, B.D., Naglich, J.G. and Eidels, L. (1993) Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen. Proc Natl Acad Sci USA, 90, 8184-8188.
33. Iwamoto, R., Higashiyama, S., Mitamura, T. Taniguchi, N., Klagsbrun, M. and Mekada, E. (1994) Heparin-binding EGF-like growth factor, which acts as diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J, 13, 2322-2330.
34. Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M. and Mekada, E. (1995) The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol, 128, 929-938.